Marc Gitzinger

Marc is the Chief Executive Officer and co-founder of BioVersys. He has over 10 years of experience in the biotech industry, having launched a university spin-off in the field of antimicrobial resistance and growing it into a multi-asset early clinical-stage company. These assets address significant unmet medical needs in infectious diseases such as tuberculosis and hospital-acquired Acinetobacter infections. He has raised over $30 million in equity financing and established several important partnerships with big pharma and other R&D organizations. Marc is a multi-award-winning Biotech CEO, having received amongst others the Swiss Technology Award 2011, Venture Kick 2009, and Venture Leaders 2008 and 2017 awards for his work in founding and advancing BioVersys. He is also vice-president of the board of the BEAM Alliance, a European association representing over 60 European and international SMEs active in antimicrobial research and development, and a board member of the AMR Industry Alliance.